Background: Women with an inherited pathogenic variant in BRCA 1 or BRCA 2 have a
greatly increased risk of developing ovarian cancer, but the importance of behavioral factors …

Background: Several reproductive and hormonal factors are known to be associated with
ovarian cancer risk in the general population, including parity and oral contraceptive (OC) …

Abstract Background BRCA1 and BRCA2 (BRCA) mutation carriers face a high lifetime risk
of developing ovarian cancer. Oral contraceptives are protective in this population; however …

Objective: To determine whether oral contraceptive (OC) use, childbearing, breastfeeding
and tubal ligation differ between ovarian cancer cases with and without a BRCA1/2 …

Objective Women with ovarian cancer who have a pathogenic germline variant in BRCA1 or
BRCA2 (BRCA) have been shown to have better 5-year survival after diagnosis than women …

In the general population, ovarian cancer risk is inversely associated with oral contraceptive
use, tubal ligation, and childbearing. Among carriers of BRCA1 gene mutations, the data are …

Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and
ovarian cancer. A genome‐wide association study (GWAS) identified six alleles associated …

Background Several of the known risk factors for ovarian cancer are thought to act through
their effects on ovulation and the menstrual cycle, such as parity, breastfeeding, and use of …

Purpose: No formal assessment of life expectancy in women with BRCA1 and BRCA2
mutations in these genes has been reported previously. We have evaluated life expectancy …

This observational study aimed to investigate whether the reported association between
family history (FH) of breast cancer (BC) or ovarian cancer (OC) and OC risks in BRCA1/2 …